INSTRuCT:印度卒中临床试验网络方案、基础设施与治理
印度医学研究理事会资助建立INSTRuCT卒中临床试验网络,旨在开展药理学与非药理学卒中临床试验。该文阐述多中心网络的结构、范围、挑战与期望,并报告首批两项试验的启动与入组情况。
要点
- INSTRuCT是印度首个国家级卒中临床试验网络,旨在开展大规模多中心卒中试验。
- 首批启动SPRINT和RESTORE两项试验,分别针对二级预防和缺血性卒中康复。
- SPRINT试验已入组3048例患者,月均入组128.5例,首轮随访已完成。
核心结论
- INSTRuCT网络有望在未来5年完成高质量、大规模且具有全球相关性的卒中临床试验。
研究设计与样本
- 印度医学研究理事会资助的任务组项目,通过多次专家组会议确定网络范围。
- 纳入年卒中量200例且有临床试验经验的卒中中心,并设立中心协调中心、标准操作规程和数据安全监查委员会。
主要发现
- 第一阶段启动SPRINT和RESTORE两项试验,第二阶段已批准4项试验。
- SPRINT试验于2018年4月28日随机首例患者,累计入组3048例,月均128.5例,首轮随访于2019年5月27日完成。
- RESTORE试验于2019年5月22日随机首例患者,累计入组49例,月均3.7例,首轮随访于2019年8月30日完成。
临床怎么用
- 该网络为印度开展大规模多中心卒中临床试验提供了组织架构、标准操作规程和数据安全监查框架。
- SPRINT和RESTORE的启动与入组数据可为后续试验的可行性评估提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Very few large scale multicentric stroke clinical trials have been done in India. The Indian Council of Medical Research funded INSTRuCT (Indian Stroke Clinical Trial Network) as a task force project with the objectives to establish a state-of-the-art stroke clinical trial network and to conduct pharmacological and nonpharmacological stroke clinical trials relevant to the nation and globally. The purpose of the article is to enumerate the structure of multicentric stroke network, with emphasis on its scope, challenges and expectations in India. METHODS: Multiple expert group meetings were conducted by Indian Council of Medical Research to understand the scope of network to perform stroke clinical trials in the country. Established stroke centers with annual volume of 200 patients with stroke with prior experience of conducting clinical trials were included. Central coordinating center, standard operating procedures, data and safety monitoring board were formed. DISCUSSION: In first phase, 2 trials were initiated namely, SPRINT (Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India) and Ayurveda treatment in the rehabilitation of patients with ischemic stroke in India (RESTORE [Rehabilitation of Ischemic stroke Patients in India: A Randomized controlled trial]). In second phase, 4 trials have been approved. SPRINT trial was the first to be initiated. SPRINT trial randomized first patient on April 28, 2018; recruited 3048 patients with an average of 128.5 per month so far. The first follow-up was completed on May 27, 2019. RESTORE trial randomized first patient on May 22, 2019; recruited 49 patients with an average of 3.7 per month so far. The first follow-up was completed on August 30, 2019. CONCLUSIONS: In next 5 years, INSTRuCT will be able to complete high-quality large scale stroke trials which are relevant globally. REGISTRATION: URL: http://www.ctri.nic.in/; Unique Identifier: CTRI/2017/05/008507.
引用
- Pandian JD, Verma SJ, Arora D, et al. INSTRuCT: Protocol, Infrastructure, and Governance. Stroke. 2021. PMID: 34167324. doi:10.1161/STROKEAHA.120.033149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。